Antiviral activity of brincidofovir on parvovirus B19.

Abstract:

:Parvovirus B19 (B19V), a single-stranded DNA virus in the family Parvoviridae, is a human pathogenic virus responsible for a wide range of clinical manifestations. Currently there is no approved antiviral therapy for parvovirus infection. The acyclic nucleoside phosphonate cidofovir (CDV) has been demonstrated to inhibit replication of B19V in vitro. The aim of the present study was to evaluate whether brincidofovir (BCV), a novel lipid conjugate of CDV, could also inhibit B19V replication. Experiments were carried out in erythroid progenitor cells (EPCs) and UT7/EpoS1 cells, infected with B19V and cultured in the presence of different concentrations of BCV and CDV for comparison. The dynamics of viral replication was evaluated by a qPCR-based assay and the extent of inhibition of viral replication exerted by the compounds determined, along with the effect of the compounds on cell viability and cell proliferation rates. Results confirmed that BCV showed significantly higher antiviral activity against B19V compared to CDV in both cell-based systems. For BCV, the calculated EC50 values were in the range 6.6-14.3 μM in EPCs and 0.22-0.63 μM in UT7/EpoS1 cells. In comparison, the EC50 values for CDV were >300 μM in EPCs and 16.1 μM in UT7/EpoS1 cells. Concurrently, the effects on cell viability were observed at a much higher concentration of BCV, with calculated CC50 values in the range 93.4-102.9 μM in EPCs and 59.9-66.8 μM in UT7/Epos1. The antiviral activity was observed specifically with the metabolically active stereoisomer of BCV suggesting that CDV-diphosphate, the metabolite of both BCV and CDV, was the active antiviral. Our results support a selective role for BCV in the inhibition of B19 viral replication.

journal_name

Antiviral Res

journal_title

Antiviral research

authors

Bua G,Conti I,Manaresi E,Sethna P,Foster S,Bonvicini F,Gallinella G

doi

10.1016/j.antiviral.2018.12.003

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

22-29

eissn

0166-3542

issn

1872-9096

pii

S0166-3542(18)30539-4

journal_volume

162

pub_type

杂志文章
  • Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon α therapy efficiency of chronic hepatitis B.

    abstract::Certain host genetic polymorphisms in human leukocyte antigen (HLA) genes are reported to be associated with response to interferon α (IFNα) therapy. Two hundred and eighteen IFNα treatment-naïve chronic hepatitis B (CHB) patients were enrolled in the present study. HLA-A, B, C and DQA1, DQB1, DRB1 gene alleles were d...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.01.001

    authors: Zhu X,Du T,Wu X,Guo X,Niu N,Pan L,Xin Z,Wang L,Li Z,Li H,Liu Y

    更新日期:2011-03-01 00:00:00

  • A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.

    abstract::Development of efficient and safer vaccines against foot-and-mouth disease virus (FMDV) is a must. Previous results obtained in our laboratory have demonstrated that DNA vaccines encoding B and T cell epitopes from type C FMDV, efficiently controlled virus replication in mice, while they did not protect against FMDV c...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.07.017

    authors: Borrego B,Argilaguet JM,Pérez-Martín E,Dominguez J,Pérez-Filgueira M,Escribano JM,Sobrino F,Rodriguez F

    更新日期:2011-11-01 00:00:00

  • Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.

    abstract::Japanese encephalitis virus (JEV) infection is a major cause of acute viral encephalitis both in humans and animals. The domain III of virus envelope protein (EDIII) plays important roles in interacting with host cell receptors to facilitate virus entry. In this study, recombinant JEV EDIII was expressed and purified....

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2012.03.002

    authors: Li C,Zhang LY,Sun MX,Li PP,Huang L,Wei JC,Yao YL,Isahg H,Chen PY,Mao X

    更新日期:2012-05-01 00:00:00

  • Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.

    abstract::A fatty acid derivative of ganciclovir (GCV), elaidic acid ganciclovir (E-GCV), has been evaluated for its inhibitory activity against laboratory and clinical strains of herpes simplex type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) in human embryonic lung fibroblasts. ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(00)00070-x

    authors: Andrei G,Snoeck R,Neyts J,Sandvold ML,Myhren F,De Clercq E

    更新日期:2000-03-01 00:00:00

  • Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells.

    abstract::Using several herbal extracts, we investigated whether certain Kampo medicines exert an inhibitory effect on the acidification of intracellular compartments such as endosomes and lysosomes (referred to as ELS), and thereby inhibit the growth of influenza A virus in Madin-Darby canine kidney cells. The vital fluorescen...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(99)00067-4

    authors: Mantani N,Andoh T,Kawamata H,Terasawa K,Ochiai H

    更新日期:1999-12-31 00:00:00

  • In vitro and in vivo influenza virus-inhibitory effects of viramidine.

    abstract::Viramidine, the 3-carboxamidine derivative of ribavirin, was effective against a spectrum of influenza A (H1N1, H3N2 and H5N1) and B viruses in vitro, with the 50% effective concentration (EC50) ranging from 2 to 32 microg/ml. The mean 50% cytotoxic concentration (CC50) in the MDCK cells used in these experiments was ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2005.06.003

    authors: Sidwell RW,Bailey KW,Wong MH,Barnard DL,Smee DF

    更新日期:2005-10-01 00:00:00

  • Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.

    abstract::As has been established in rabbits, (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) is superior to 5-iodo-2'-deoxyuridine (IDU) in the topical treatment of epithelial HSV-1 (herpes simplex virus type 1) keratitis, and superior to 5-trifluoromethyl-2'-deoxyuridine (TFT) in the topical treatment of deep stromal HSV-1 kerati...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(84)90033-0

    authors: Maudgal PC,De Clercq E,Missotten L

    更新日期:1984-10-01 00:00:00

  • Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP).

    abstract::Itraconazole (ITZ) is a well-known, FDA-approved antifungal drug that is also in clinical trials for its anticancer activity. ITZ exerts its anticancer activity through several disparate targets and pathways. ITZ inhibits angiogenesis by hampering the functioning of the vascular endothelial growth receptor 2 (VEGFR2) ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2018.05.010

    authors: Bauer L,Ferla S,Head SA,Bhat S,Pasunooti KK,Shi WQ,Albulescu L,Liu JO,Brancale A,van Kuppeveld FJM,Strating JRPM

    更新日期:2018-08-01 00:00:00

  • Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development.

    abstract::Rotavirus infection has emerged as an important cause of complications in organ transplantation recipients. Immunosuppressants used to prevent alloreactivity can also interfere with virus infection, but the direct effects of the specific type of immunosuppressants on rotavirus infection are still unclear. Here we prof...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.07.017

    authors: Yin Y,Wang Y,Dang W,Xu L,Su J,Zhou X,Wang W,Felczak K,van der Laan LJ,Pankiewicz KW,van der Eijk AA,Bijvelds M,Sprengers D,de Jonge H,Koopmans MP,Metselaar HJ,Peppelenbosch MP,Pan Q

    更新日期:2016-09-01 00:00:00

  • Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.

    abstract::In the present study, the protective effect of 1T1, a lambda-carrageenan extracted from the red seaweed Gigartina skottsbergii was evaluated in a murine model of herpes simplex virus type 2 (HSV-2) genital infection. Six to eight-week-old female BALB/c mice were intravaginally inoculated with a lethal dose of HSV-2 (M...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2004.07.001

    authors: Carlucci MJ,Scolaro LA,Noseda MD,Cerezo AS,Damonte EB

    更新日期:2004-11-01 00:00:00

  • Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin.

    abstract::Schefflera heptaphylla is a popular medicinal plant in southern China. Three caffeoylquinic acid derivatives, namely 3,4-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid, and 3-O-caffeoylquinic acid, were isolated from this plant and investigated for their antiviral activity against respiratory syncytial virus (...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2005.06.004

    authors: Li Y,But PP,Ooi VE

    更新日期:2005-10-01 00:00:00

  • Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.

    abstract::Foot and mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. Previously, we found that the epitope peptide EP141-160 displayed on virus-like particles (VLP) for use as a vaccine showed high immunoreactivity and conferred partially effective protection to animals. In this study, we first ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.08.020

    authors: Dong YM,Cai JC,Chen HT,Chen L

    更新日期:2016-10-01 00:00:00

  • Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.

    abstract::Infection with the oncogenic γ-herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) cause several severe malignancies in humans. Inhibition of the lytic replication of EBV and KSHV eliminates the reservoir of persistent infection and transmission, consequently preventing the occurr...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.12.002

    authors: Huang L,Yang M,Yuan Y,Li X,Kuang E

    更新日期:2017-02-01 00:00:00

  • Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.

    abstract::Previously, we found that a ganciclovir (GCV)-resistant clinical human cytomegalovirus (HCMV) isolate had an amino acid substitution at codon 501 (Leu --> Phe) in the delta-region C of the DNA polymerase gene. DNA polymerases have now been (partially) purified from both the GCV-resistant and sensitive parental strains...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(00)00063-2

    authors: Kariya M,Mori S,Eizuru Y

    更新日期:2000-02-01 00:00:00

  • Rift Valley fever virus: Unanswered questions.

    abstract::This mosquito-borne pathogen of humans and animals respects no international or geographic boundaries. It is currently found in parts of Africa and the Arabian Peninsula where periodic outbreaks of severe and fatal disease occur, and threatens to spread into other geographic regions. In recent years, modern molecular ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2016.07.005

    authors: Bird BH,McElroy AK

    更新日期:2016-08-01 00:00:00

  • Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activity.

    abstract::Novel L-lyxo-TSAO-T analogs with an inverted configuration at the C-4'-position of the sugar moiety and 5'-deoxy-5'-modified TSAO-T derivatives have been prepared and evaluated for their inhibitory effect on human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) replication in cell culture. None of the compoun...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(95)00989-2

    authors: Ingate S,De Clercq E,Balzarini J,Camarasa MJ

    更新日期:1996-11-01 00:00:00

  • Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK.

    abstract::Human cytomegalovirus infection can lead to life-threatening clinical manifestations particularly in the immunocompromised host. Current therapy options face severe limitations leading to a continued search for alternative drug candidates. Viral replication is dependent on a balanced interaction between viral and cell...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.04.017

    authors: Hutterer C,Wandinger SK,Wagner S,Müller R,Stamminger T,Zeitträger I,Godl K,Baumgartner R,Strobl S,Marschall M

    更新日期:2013-08-01 00:00:00

  • The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.

    abstract::The hepatitis B virus nucleocapsid or core antigen is extremely immunogenic during infection and after immunization. This review summarizes several features of the nucleocapsid which explain this exceptionally high immunogenicity: a unique three-dimensional folding, the presence of a region that interacts with immunog...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2003.08.011

    authors: Vanlandschoot P,Cao T,Leroux-Roels G

    更新日期:2003-10-01 00:00:00

  • The effect of HSV multiplication rate on antiviral drug efficacy in vitro.

    abstract::HSV-1 multiplication rates have been shown to vary in different tissues and the rate of multiplication may correlate with susceptibility to antiviral chemotherapy. Herpetic stromal keratitis is a necrotizing condition refractive to antiviral therapy and this lack of antiviral efficacy in stromal disease may be the res...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(91)90041-o

    authors: Upadhyay JM,Hill JM,Jemison M,Helmy MF,Kaufman HE

    更新日期:1991-01-01 00:00:00

  • Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?

    abstract::High-throughput genomic methods are now being used to study a wide variety of viral diseases, in an effort to understand how host responses to infection can lead either to efficient elimination of the pathogen or the development of severe disease. This article reviews how gene expression studies are addressing importa...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2008.12.005

    authors: Walters KA,Katze MG

    更新日期:2009-03-01 00:00:00

  • Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives.

    abstract::Several novel γ-carboline derivatives were identified as selective inhibitors of bovine viral diarrhea virus (BVDV) replication in cell cultures. Among them, 3,4,5-trimethyl-γ-carboline (SK3M4M5M) was the most active against BVDV (Nose strain) in MDBK cells, with a 50% effective concentration of 0.017±0.005μM and a se...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2010.09.013

    authors: Salim MT,Goto Y,Hamasaki T,Okamoto M,Aoyama H,Hashimoto Y,Musiu S,Paeshuyse J,Neyts J,Froeyen M,Herdewijn P,Baba M

    更新日期:2010-12-01 00:00:00

  • Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins.

    abstract::Hepatitis C virus (HCV) is a leading cause of chronic hepatitis and end-stage liver diseases. Mature HCV virions are bound by host-derived lipoproteins. Lack of an HCV vaccine warrants a major role of antiviral treatment in the global elimination of hepatitis C. Although direct-acting antivirals (DAAs) are replacing t...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104734

    authors: Li X,Li J,Feng Y,Cai H,Li YP,Peng T

    更新日期:2020-05-01 00:00:00

  • Antiviral agents alter ability of HSV-2 to disrupt gap junctional intercellular communication between mammalian cells in vitro.

    abstract::In cultured mammalian cells (Vero), different antiviral agents change to differing degrees the ability of HSV2 to down-regulate gap junctions, each agent having a specific effect. Measured by intracellular electrodes, control cell populations showed 49-51% coupling, uninfected populations treated with acyclovir or SDS...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(02)00106-7

    authors: Musée J,Mbuy GN,Woodruff RI

    更新日期:2002-11-01 00:00:00

  • A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.

    abstract::T Follicular helper cells (TFH) are considered critical for B cell antibody response, and recent efforts have focused on promoting TFH in order to enhance vaccine efficacy. We studied the frequency and function of TFH in nasopharynx-associated lymphoid tissues (NALT) from children and adults, and its role in anti-infl...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.05.021

    authors: Aljurayyan AN,Sharma R,Upile N,Beer H,Vaughan C,Xie C,Achar P,Ahmed MS,McNamara PS,Gordon SB,Zhang Q

    更新日期:2016-08-01 00:00:00

  • Nanobodies®: new ammunition to battle viruses.

    abstract::In 1989, a new type of antibody was identified, first in the sera of dromedaries and later also in all other species of the Camelidae family. These antibodies do not contain a light chain and also lack the first constant heavy domain. Today it is still unclear what the evolutionary advantage of such heavy chain-only a...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2011.09.002

    authors: Vanlandschoot P,Stortelers C,Beirnaert E,Ibañez LI,Schepens B,Depla E,Saelens X

    更新日期:2011-12-01 00:00:00

  • Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro.

    abstract:BACKGROUND:By modulating the antiviral immune response via vitamin D receptor, the active form of vitamin D (1,25-dihydroxyvitamin D, calcitriol) could play a central role in protection against respiratory virus infections. This in vitro study tested the hypothesis that respiratory viruses modulate vitamin D receptor e...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.11.004

    authors: Telcian AG,Zdrenghea MT,Edwards MR,Laza-Stanca V,Mallia P,Johnston SL,Stanciu LA

    更新日期:2017-01-01 00:00:00

  • Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.

    abstract::Endoplasmic reticulum (ER)-resident α-glucosidases I and II sequentially trim the three terminal glucose moieties on N-linked glycans attached to nascent glycoproteins. These reactions are the first steps of N-linked glycan processing and are essential for proper folding and function of many glycoproteins. Because mos...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2013.06.011

    authors: Chang J,Block TM,Guo JT

    更新日期:2013-09-01 00:00:00

  • The potential use of influenza virus as an agent for bioterrorism.

    abstract::Influenza A virus has been responsible for widespread human epidemics because it is readily transmitted from humans to humans by aerosol. Recent events have highlighted the potential of influenza A virus as a bioterrorist weapon: the high virulence of the influenza A virus that infected people in Hong Kong in 1997; an...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/s0166-3542(02)00207-3

    authors: Krug RM

    更新日期:2003-01-01 00:00:00

  • Antiviral activity of serum from the American alligator (Alligator mississippiensis).

    abstract::Serum from wild alligators was collected and tested for antibiotic activity against three enveloped viruses using cell-based assays. Alligator serum demonstrated antiviral activities against human immunodeficiency virus type 1 (HIV-1; IC50=0.9%), West Nile virus (WNV; IC50=4.3%), and Herpes simplex virus type 1 (HSV-1...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2004.12.007

    authors: Merchant ME,Pallansch M,Paulman RL,Wells JB,Nalca A,Ptak R

    更新日期:2005-04-01 00:00:00

  • Dual biological activity of apurinic acid on human lymphocytes: induction of interferon-gamma and protection from human immunodeficiency virus infection in vitro.

    abstract::The chemically modified DNA, apurinic acid (APA), is cytotoxic for human lymphocytes at concentrations above 100 micrograms/ml. At low concentrations (0.05-1 micrograms/ml) APA acts as an inducer interferon gamma (IFN-gamma) in lymphocytes in vitro; the maximum interferon titer of 50 units/ml was reached at 0.4 microg...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(88)90003-4

    authors: Müller WE,Sarin PS,Sun D,Rossol S,Voth R,Rottmann M,Hess G,Meyer zum Büschenfelde KH,Schröder HC

    更新日期:1988-04-01 00:00:00